Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKA | O14965 | 6/20 | 0.69 |
| ▸ | AURKB | Q96GD4 | 4/20 | 0.69 |
| ▸ | KDR | P35968 | 9/20 | 0.61 |
| ▸ | EGFR | P00533 | 3/20 | 0.60 |
| ▸ | RAF1 | P04049 | 1/20 | 0.56 |
| ▸ | BRAF | P15056 | 1/20 | 0.56 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5652035 | 0.91 | AURKA (0.68) | AURKAAURKBKDREGFRMAPK14 | |
| SCHEMBL5651730 | 0.91 | AURKB (0.81) | AURKAAURKBKDREGFRMAPK14 | |
| Hydrochloric Acid SCHEMBL2463942 | 0.90 | AURKB (0.80) | AURKAAURKBKDREGFRMAPK14 | |
| SCHEMBL5023544 | 0.89 | AURKA (0.67) | AURKAAURKBKDREGFRRAF1 | |
| SCHEMBL5016550 | 0.85 | KDR (0.74) | AURKAAURKBKDREGFRRAF1 | |
| SCHEMBL5655354 | 0.85 | EGFR (0.65) | AURKAAURKBKDREGFRMAPK14 | |
| SCHEMBL14964757 | 0.81 | EGFR (0.81) | KDREGFRRAF1BRAF | |
| SCHEMBL3531809 | 0.81 | AURKB (1.00) | AURKAAURKBKDREGFRMAPK14 | |
| SCHEMBL6689820 | 0.79 | AURKB (0.73) | AURKAAURKBKDREGFR | |
| SCHEMBL10152557 | 0.79 | AURKA (0.69) | AURKAAURKBKDREGFRMAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7235559-B1 | Therapeutic quinazoline derivatives | ASTRAZENECA AB (SE) | 2007-06-26 | — | — | US | disclosed |
| EP-1218355-A1 | THERAPEUTIC QUINAZOLINE DERIVATIVES | AstraZeneca AB (SE) | 2002-07-03 | — | — | EP | disclosed |
| WO-2001021597-A1 | THERAPEUTIC QUINAZOLINE DERIVATIVES | ASTRAZENECA AB (SE) | 2001-03-29 | — | — | WO | disclosed |